9/27/26
Dalian Haosen Equipment Manufacturing (688529.SS) Thesis The ongoing decline in automotive production and rising raw material costs are leading to a more negative outlook for the company’s revenue and margins.
★ Analysts see FY2026 revenue reaching $2.0B — +38.1% growth in a single year.
What Could Go Wrong 01 Recent reports indicate a 15% decline in automotive production in China, which could further pressure revenue. 02 Rising steel prices have led to increased production costs, which could further compress margins in the upcoming quarters. 03 Technological disruption from advanced manufacturing techniques such as 3D printing 04 Regulatory changes impacting environmental standards in manufacturing 05 Emergence of low-cost competitors in the machinery sector 06 Potential consolidation among key customers reducing pricing power 07 High debt-to-equity ratio (1.79) indicates potential liquidity issues 08 Negative net margins raise concerns about long-term sustainability 11.1 13.7 16.4 19.0 21.7 15.60 688529.SS Daily 15.60 May '26 Jun '26 Aug '26 Sep '26
My Notes "Management noted, 'We are facing unprecedented challenges in maintaining profitability amidst declining production volumes.'" Moat: The company's engineering expertise provides a competitive edge, but this is increasingly challenged by low-cost competitors. Watch: The rise of automation and smart manufacturing technologies poses a significant threat to traditional machinery manufacturers. value - Investors may be attracted to the stock due to its low price-to-sales ratio despite current operational challenges. Higher interest rates can increase financing costs for capital expenditures, potentially reducing demand for new machinery as companies may… Watch on earnings: Automotive production rates in China, Steel and aluminum price indices, Industrial production index in China. One Sentence Summary: The bear case: recent reports indicate a 15% decline in automotive production in china, which could further pressure revenue.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.